Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany3,4-Diaminobenzophenone 98%
3,4-Diaminobenzophenone
3,4-Diaminobenzophenone
3,4-Diaminobenzophenone

3,4-Diaminobenzophenone 98%

Price Get Latest Price
Packge 1kg5kg10kg25kg
  • Min. Order:10kg
  • Time:2024-01-05

Product Details

  • Product Name3,4-Diaminobenzophenone
  • EINECS No.254-273-8
  • MFC13H12N2O
  • MW212.25
  • InChIKeyRXCOGDYOZQGGMK-UHFFFAOYSA-N
  • AppearancePowderYellow to ochre-yellow
  • Water Solubility 410 mg/L (20 ºC)
  • Melting point 115-117 °C (lit.)
  • storage temp. Store below +30°C.
  • Boiling point 352.09°C (rough estimate)
  • density 1.1128 (rough estimate)

Company Profile Introduction

AbilityPharma is a clinical-stage biopharmaceutical company focused on developing first-in-class fully differentiated oral targeted anticancer compounds that produces autophagy-mediated cytotoxicity selectively in cancer cells. 

The first drug candidate, ABTL0812, is currently in phase 2b clinical trials in pancreatic cancer in Spain, USA, France, and Israel. The product has also completed with positive results a phase 2a trial in endometrial cancer and squamous non-small cell lung cancer in Spain and France.

The phase 2a trial in endometrial cancer and lung cancer was conducted in Vall d’Hebron Institute of Oncology (VHIO, Barcelona), Institut Gustave Roussy (Paris), Centre Léon-Bérard (Lyon), Institut Català d’Oncologia (ICO, L'Hospitalet, Badalona and Girona), INCLIVA (Valencia), Institut Paoli-Calmettes (Marseille) and Hospital Universitario Virgen del Rocío (Sevilla)

Ability Life Sciences

1Y Telangana India
  • Since:2020-01-01
  • Address: Survey No. 285, KK Owners Association, IDA Doolapally, Jeedimetla, Hyderabad, Telangana-500 055, Ind
INQUIRY